Finally, we recently showed that μCP-printed human plasma from Alzheimer’s disease (AD) patients decreased the migration of Iba1+ microglia along the plasma, allowing the identification of novel biomarkers (Steiner et al., 2024). This evidence concerns the gene AIF1 and Alzheimer disease.